Literature DB >> 12439809

High rate of monoclonal gammopathy among immunocompetent subjects with primary cytomegalovirus infection.

Suvi Bühler1, Kalevi Laitinen, Harry Holthöfer, Asko Järvinen, Knut-Olof Schauman, Klaus Hedman.   

Abstract

Serum samples from immunocompetent adults with primary cytomegalovirus (CMV) or Epstein-Barr virus (EBV) infection and from solid-organ or bone marrow transplant recipients with primary CMV infection were examined for paraproteins. Several immunocompetent patients with CMV infection but none with EBV infection presented with an M component, which implies that the M component connects CMV infection to a risk of B cell malignancy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12439809     DOI: 10.1086/344465

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  5 in total

Review 1.  Presentation of multiple myeloma occurring in the humerus after strain: a case report.

Authors:  Ebru Yilmaz
Journal:  Clin Rheumatol       Date:  2020-07-01       Impact factor: 2.980

2.  Fever of unknown origin (FUO) in an immunocompetent adult due to cytomegalovirus (CMV) with polyclonal gammopathy.

Authors:  B A Cunha; J E Hage; Y Nouri
Journal:  Infection       Date:  2011-09-15       Impact factor: 7.455

3.  Accurate identification of paraprotein antigen targets by epitope reconstruction.

Authors:  Seshi R Sompuram; Gerassimos Bastas; Kodela Vani; Steven A Bogen
Journal:  Blood       Date:  2007-09-18       Impact factor: 22.113

4.  Epidemiologic analysis of reactivated cytomegalovirus antigenemia in patients with cancer.

Authors:  Xiang Y Han
Journal:  J Clin Microbiol       Date:  2007-02-07       Impact factor: 5.948

5.  Case Report: Monoclonal Gammopathy of Undetermined Significance is Associated with Loa loa Infection.

Authors:  Derek B Laskar; Michael Rose; Raavi Gupta; Herbert B Tanowitz; M A Haseeb
Journal:  Am J Trop Med Hyg       Date:  2018-11       Impact factor: 2.345

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.